BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 9291432)

  • 1. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p150 in cervical neoplasia and its potential value in predicting survival.
    Dellas A; Torhorst J; Bachmann F; Bänziger R; Schultheiss E; Burger MM
    Cancer; 1998 Oct; 83(7):1376-83. PubMed ID: 9762939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L; Baker P; Gup C; Shroyer KR
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
    Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
    Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
    Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
    J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, MDM2, and p21 proteins in high-grade cervical intraepithelial neoplasia and relationship to human papillomavirus infection.
    Lie AK; Skarsvåg S; Skomedal H; Haugen OA; Holm R
    Int J Gynecol Pathol; 1999 Jan; 18(1):5-11. PubMed ID: 9891236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
    Sano T; Masuda N; Oyama T; Nakajima T
    Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 and MDM2 proteins in cervical neoplasia.
    Lukás Z; Vojtĕsek B; Anton M; Picksley SM; Kubálek V
    Folia Biol (Praha); 1995; 41(3-4):197-9. PubMed ID: 7589715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus.
    Carlson JA; Amin S; Malfetano J; Tien AT; Selkin B; Hou J; Goncharuk V; Wilson VL; Rohwedder A; Ambros R; Ross JS
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):150-63. PubMed ID: 11396633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
    Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
    Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
    Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
    Feng W; Xiao J; Zhang Z; Rosen DG; Brown RE; Liu J; Duan X
    Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining.
    Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ
    Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.